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Application of Microfluidics 
in Biosensors
Jing Wang, Yong Ren and Bei Zhang
Abstract
This chapter reviews the up-to-date researches in the field of biosensors inte-
grated with microfluidic techniques, most of which are publications within the last 
5 years. The features of these biosensors, their applications, challenges, and possible 
future research interests in this field are also reviewed.
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1. Introduction
Biosensors are defined, by Tudos and Schasfoort [1], as “analytical devices 
comprised of a biological element (tissue, microorganism, organelle, cell recep-
tor, enzyme, antibody) and a physicochemical transducer. Specific interaction 
between the target analyte and the biological material produces a physico-chemical 
change detected by the transducer. The transducer then yields an analog electronic 
signal proportional to the amount (concentration) of a specific analyte or group of 
analytes” [1]. The features of biosensors include the bio-recognition unit and the 
transduction mechanism from biological signals to measurable electronic signals, 
e.g., color, current, voltage, capacitance, light intensity, wavelength, and phase. 
Major parameters to assess the performances of biosensors include the following:
• High sensitivity. The sensitivity of a biosensor is always the first and one of 
the most important parameters in assessing its performance. The efficiency in 
capturing analytes, the specific characterization of the analyte, the capability 
of converting biological signals into electronic signals (or the response of the 
system), and the systematic and environmental noises both determine the 
sensitivity of a biosensor.
• High stability and repeatability. The stability of a biosensor refers to the 
capability of a biosensor in performing consistently and reliably under desig-
nated environments, and the stability of a biosensor is especially important 
when assessing portable or wearable biosensors that usually are applied in 
scenarios involving varied temperature, velocity, humidity, pressure, lighting 
conditions, etc. The repeatability of a biosensor mainly refers to the long-term 
performance of a biosensor under the same conditions and is usually tested 
regularly in commercial biosensors in order to recalibration.
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• Quick response or real-time analysis and diagnosis. Real-time analysis usually 
delivers more information than providing a final result, e.g., binding rate, reac-
tion time, kinetics, and saturation conditions, which can serve for the analysis 
in the applications of biological and chemical reactions and drug analysis. 
Response time required to bind sufficient molecules upon the sensing surface 
is typically determined by diffusion, which can extend to hours and even to 
days to generate a signal above the background noise level. This applies funda-
mentally to all sensors that accumulate and concentrate target molecules onto 
a transducer, including fluorophore-tagged molecules in microarray spots, 
label-free optical biosensors, and impedance-based sensors [2].
• Low consumption of sample volume. The samples for biosensors are usually 
with low volume due to the nature, e.g., tissue, antibody, and some biologi-
cal samples are with low concentration or small molecular weight, and this 
enforces biosensors to perform with minimum sample consumption.
• Ease of operation. The application of biosensors goes from laboratory-based 
research to commercially available devices for at-home use. The operation of 
biosensors should eliminate professional operation or understanding of the 
device, but simply involves collecting samples and reading results.
• High throughput. Single-function biosensors are fading away from stage even 
with extremely low cost. Biosensors should be able to integrate all the good 
qualities mentioned in above bullet points together with the capability of 
multiple-tasking.
In traditional clinical healthcare, interests are in high-quality biosensor for the 
measurement of physiological indices. With the development in the requests of 
Internet of Things and self-service techniques, the interests and emphasis in health-
care transfers from clinical healthcare to family healthcare, e.g., long-term monitor-
ing of chronic disease [3], disease prevention and early detection, reachable clinical 
services for remote districts, etc. Under the precondition of high quality, biosensors 
miniaturized as portable or wearable are emerging to meet the new trend of era, 
which promise a bright future in health management and digital health; researches 
on the biological and instrumental parts of point-of-care (POC) and lab-on-a-chip 
(LOC) techniques belong to this area. The potential applications of biosensors 
include real-time health monitoring, remotely synchronizing health data with 
medical personnel, patient management, POC disease diagnosis, big data statistics 
in health management, etc. [4]. Real-time health monitoring in domestic applica-
tions enables patients to monitor the health status by themselves at home without the 
assistance of professional personnel at minimum cost. Health data synchronized with 
medical personnel spares the patients from transporting and waiting for outpatient 
services, saving time and reducing medical expenses. Based on the collected health 
data, a potential service of clinical diagnosis is possible in an artificial intelligent 
health system in the near future [5]. Meanwhile, these new applications impose more 
requirements on the researches and developments of biosensors, as stated below.
• Low cost. For at-home applications, lower cost of biosensors is vital, so there 
are emerging researches on adopting cheap materials, simplifying sensing 
systems and adopting smart phones in data processing, etc.
• Noninvasive collection of samples. Biosensors for sensing human samples, 
noninvasive sensing, is preferable, especially for everyday or frequent 
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measurements. Researches using human samples as saliva, tear, sweat, and 
urine are one of the hottest topics.
• Miniaturization of the biosensing systems [4, 5], including sample pre-
processing unit, sensing unit, data collection/processing system, and data 
displaying unit.
• The design of integrated sensor chip. A sensor chip with multiple functions is 
preferable especially for sensing human samples.
2. Challenges in biosensing technologies
All the qualities mentioned above, which both researchers and industry are seek-
ing for, raise multiple challenges, and we try to summarize and list below:
• Specific binding. The recognition of analytes should be specific only to the 
analytes which is not affected by other chemicals, molecules, or cells. This 
is significantly more challenging when the sample components are complex 
and mixed with various kinds of molecules. For example, the detection of one 
specific antibody in human blood sample should eliminate the effects of all 
other antibodies, cells, electrolytes, etc., the detection reflects only the concen-
tration of this antibody, and the detection of one specific heavy metal ion in a 
real polluted water sample should be able to distinguish the reaction induced 
by all other ions.
• Non-specific binding, i.e., biofouling, in some cases significantly introduces 
signal noise, drift, or delay in biosensors [6]. The most common method to 
reduce non-specific binding is to completely wash the binding surface with 
buffer after the binding processing is finished; thus the weak binding induced 
by non-specific binding could be eliminated to the minimum extent.
• Properties of bioreceptors, e.g., concentration and alignment. Plenty of 
papers [3, 7–10] presented the protocols of surface activation, modification, 
and functionalization, but the protocols greatly depend on operation and 
environment. Even following exactly the same protocol, the coverage rate 
of bioreceptors and the repeatability of operation may vary a lot, due to the 
immobilization of multiple layers on the sensor surface, which usually involves 
linking layers for stable sensor surfaces like gold and silicon, so the surface 
treatment protocols should be tested before operating the binding events. So 
far quite limited number of papers presented theoretical and/or experimental 
analysis on the effect of bioreceptor alignment/orientation on the performance 
of biosensors. The linking layer molecules are usually randomly polarized and 
oriented, which can induce destructive interference and dramatically reduce 
the collective charge polarization [11], and this means that even the surface 
treatment protocols could be repeated and the alignment of bioreceptors is 
another parameter that will highly affect the outcomes of the binding events. 
The detection becomes less sensitive. Chu [12] proposed a method to homog-
enize the orientation of the chemical linker on nanowire-based field-effect 
sensor by applying an external voltage on a metal plate about 1 mm above the 
chip surface at certain frequency while grounding the back gate electrode; thus 
the molecular conformation can be maintained for hours or longer, and this 
method has been tested and proven by the detection of DNA hybridization 
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reactions with poly-15 T ssDNA, showing that the alignment process promotes 
the sensitivity by 10-fold.
• Design of biosensor assay matrix. The effects of specific and non-specific 
binding on signal was tested and analyzed by Schneider [13, 14], which proves 
that for all the binding events, proper design of the sensor assay should be 
optimized, especially when the sample components is complex, for example, 
proper reference binding sites should be included in order to eliminate non-
specific binding from different components. But this in another way increased 
the requirement in both the imaging capability of the biosensor and the data 
processing capability. Meanwhile, the surface treatment, modification, and 
functionalization [4, 7, 9, 10, 15, 16] will be more complicated and need to be 
tested and verified, and the complexity in sensor surface properties (e.g., vari-
ous refractive indices of bioreceptors) requests better system compatibility 
and responsivity.
• Low concentration target molecule within a low-volume sample, i.e., extremely 
limited number of analytes available for detection. For the example, in the 
research of POC and LOC, 20–50 μL finger prick blood contains over 20,000 
kinds of biomarkers of clinical interest at concentrations as low as 10 pg./mL, 
meaning that only 106–107 available biomolecules for one target [2].
3. What is microfluidics?
The definition of microfluidics, given by Whitesides from Harvard University, is:
It is the science and technology of systems that process or manipulate small 
amounts (10−9 to 10−18 liters) of fluids, using channels with dimensions of tens to 
hundreds of micrometers. It offers fundamentally new capabilities in the control of 
concentrations of molecules in space and time [17].
The material most commonly adopted for the fabrication of microfluidic struc-
tures is poly-dimethylsiloxane (PDMS), which is optically transparent and able to 
support important microfluidic components, e.g., pneumatic valves; meanwhile 
there are other materials with research interests, e.g., polycarbonate, polyolefin, 
silicon, and glass. Recently paper-based (reviews by [3, 18–21], and research by 
[22–28]) and cloth-based [29] microfluidics are drawing more attention because 
of the low cost, easy fabrication, and lightweight which are essential properties for 
POC applications. The major features of microfluidics are the small consumption of 
liquid sample and tiny dimensions of structures, which have significant impact on 
the development of biosensors, so the integration of microfluidics into biosensing 
techniques complies with the development of the era and generates unique features 
in biosensors, e.g., trace level of sample at high sensitivity.
4. Advantages of microfluidic-integrated biosensors
Microfluidics provide a closed and stable biosensing environment so to 
improve sensitivity. For on-site portable biosensors, the effect of an open envi-
ronment on sensing results hugely lowers the biosensor performance. By integrat-
ing the microfluidic structures, sample processing and biosensing reactions are 
carried out within a closed and relatively stable environment, thus promising 
better sensitivity and reliability [30]. Taking the example of the application of 
solid-phase polymerase chain reaction (SP-PCR) in online molecular diagnosis, the 
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development of this technique is hindered by lack of sensitive and portable on-chip 
optical detection technology. Hung [24] proposed a LOC device which combined 
the solid-phase polymerase chain reaction with supercritical angle fluorescence 
(SAF) microlens array embedded in a microchip. He demonstrated a high sensitiv-
ity of 1.6 copies/μL and showed comparable detection limit and linear range to 
off-chip detection using conventional laser scanner, and he stated this device as 
an on-chip highly sensitive and multiplexed pathogen detection with low-cost and 
compact optical components.
Microfluidic channel can efficiently, accurately, and significantly reduce the 
sensing area. Simulations and experiment results have shown that reducing the 
sensing area could shorten sensing time and increase the sensitivity with smaller 
sample requirement, especially at lower target concentrations [7, 11]. An increase in 
sensitivity of two orders of magnitude has been reported by Li et al. [31]. Meanwhile, 
the distribution of binding events along the sensing surface could be heterogeneous, 
and this could be induced by the heterogeneous in bioreceptor coverage, different 
alignment of bioreceptors, nonuniform concentrations of targets within samples in 
laminar flow, and nonuniform temperature, pressure, or other physical parameters 
along the sensing surface, the heterogeneity can be eliminated to minimum. Reduced 
sensing area also means miniaturizing sample volume which is essentially valuable to 
low concentration targets and rare targets with limited access.
Microfluidic structures are capable of integrating multiple functions within 
one device without introducing extra equipment or tools. For example, by 
designing and optimizing microfluidic channels, sample injection, pretreatment, 
and processing can be easily realized. Usually for biosensing, the modification of 
the biosensing surface is compulsory for specific binding of targets, and this is 
doable in microfluidic structures which are even more stable and more promising 
than manual operations. For the biosensing events, the volume and speed control 
of sample are achievable which provides more valuable information, e.g., binding 
affinity, binding rate, kinetics, etc.
Microfluidic devices are capable of automation. With or without external 
pumping system/equipment/tools, microfluidics is capable of integrating sample 
pre- and post-processing, sensing, surface modification, temperature control, EM 
field control, etc. The automation of microfluidic-integrated sensors and structures 
is reviewed by [30, 32–34]. However, the automation of whole microfluidic-inte-
grated biosensor as one device still seems quite challenging as the liquid handling 
in this field is usually more complex which could involve up to dozens of solutions 
and operations like filtering, centrifugation, etc., together with the activity of 
biological samples to be considered. Partially automized microfluidic-integrated 
DNA biosensors are reviewed by Ansari [35]. Joung [36] presented a novel lateral 
flow immunosensor (LFI) for microfluidic-integrated enzyme immunosorbent 
assay (EIA) in POC testing (POCT), a chemiluminescent LFI-based automatic EIA 
system, the operation of which does not require additional steps such as mechanical 
fluidic control, washing, or injecting. The key concept relies on a delayed-release 
effect of chemiluminescent substrates (luminol enhancer and hydrogen peroxide 
generator) by an asymmetric polysulfone membrane (ASPM). When the ASPM 
was placed between the nitrocellulose membrane and the substrate pad, substrates 
encapsulated in the substrate pad were released after 5.3 ± 0.3 min. As a proof of 
concept, the high-sensitivity C-reactive protein level in human serum was detected 
by this sensor.
Microfluidics enables both separate and mutual processing of multiple 
binding assays with single or multiple samples simultaneously. For the detec-
tion of single or multiple targets in a real or complex solution, the design of the 
binding assay usually involves more than one kind of bioreceptors, thus meaning 
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that the designed samples to flow over each bioreceptor spot could be different. 
The delivering of different kinds of samples in sequential orders can be realized by 
unique design of microfluidic channels, pneumatic valves [17, 37], and/or centrifu-
gal forces [33, 34].
Microfluidic structures ensure the precise control over experimental condi-
tions [38]. What can be precisely controlled by microfluidic structures include 
flow rate, sample volume, channel volume, channel height, reaction time, etc. 
Integration of sensors with microfluidic channels serves to reduce assay time by 
constraining the diffusion distance between the molecules in the sample and the 
sensor and to create laminar flow over the sensor to distribute target molecules 
broadly and uniformly [2].
5. The present of microfluidic-integrated biosensors
Biosensors can be classified based on target recognition events and transduction 
mechanisms [4]. Based on the target recognition events, biosensor receptors are 
included. Based on the transduction mechanisms, biosensors can be classified into 
optical biosensor (Raman scattering [39–44], surface plasmon resonance (SPR) 
[6, 45–47], fiber Bragg grating [48–53], fluorescent [54–58], chemiluminescence 
[36, 59]), electrochemical biosensor [60–64], calorimetric biosensor [6, 22, 65–69], 
and piezoelectric biosensor [70–74].
5.1 Target recognition
Biological targets to be detected by biosensors, especially for the detection of 
analytes holden by human beings/animals, could be divided into two kinds, i.e., 
physical parameters and physiological/biological targets. Physical parameters like 
the body temperature, blood pressure, heart rate, velocity, and location usually 
do not request a corresponding and unique bioreceptor on the biosensor, as these 
physical parameters usually can be detected directly by optical, electronic, and 
piezoelectric sensors. Analytes as physiological/biological targets, however, cannot 
be detected directly, because of the complex components in a real human sample, so 
bioreceptors are adopted for the specific recognition of these targets, including cell, 
antibodies, DNAs, aptamers, and molecularly imprinted polymers [4].
The most commonly adopted physiological fluids of human beings/animals are 
blood, which has to be collected in an invasive way, and fluids that can be collected 
in a noninvasive way, e.g., sweat, saliva, tears, and urine, can be used in the predic-
tion and diagnosis of various diseases [75–77]. Comparing with other physiological 
fluids, saliva is the outstanding fluid with the advantages of easy accessing and large 
volume, but with a major disadvantage of large range of variability in components 
and concentrations depending on the extent of oral cleanliness; examples that have 
been experimentally verified are using human saliva for the detection of cytokine 
[78], dopamine [51], insulin [79], fetuin [80], bacterial load [81], cholesterol 
[25], and cortisol [82]; using tear for the detection of dopamine [83], proteomic, 
lipidomic, and metabolomic composition [77]; using sweat for the detection of 
cytokine [84] and proteomic [76]; and using urine for the detection of anticancer 
drugs [85], L-carnitine [86], Chlamydia trachomatis, and Neisseria gonorrhoeae [87]. 
Samples of sweat and tear have been significantly undeveloped until quite recent 
when flexible materials and flexible electronic techniques achieved some milestones 
[4]. Currently the most well-explored targets in human physiological fluids include 
electrolytes (e.g., K+, Ca2+, Na+) and major metabolites (e.g., myocardial enzyme, 
7Application of Microfluidics in Biosensors
DOI: http://dx.doi.org/10.5772/intechopen.91929
glucose, urea), which lack specification to diseases, indicating the general physi-
ological conditions [4].
5.2 Transduction mechanism
So far, optical biosensors deliver the best sensitivity among the three other 
kinds of biosensors; electrochemical biosensors are the most popular choice as 
commercial-potential biosensors because of the compact size, low cost, and accept-
able sensitivity; colorimetric biosensors are with a distinguished advantage of easy 
operation at extremely low cost but with a major disadvantage of low sensitivity; 
while the researches on piezoelectric biosensors are quite limited comparing with 
three other kinds of biosensors. Some most up-to-date researches on all fours kinds 
of biosensors are presented below.
5.2.1 Optical biosensors
Surface-enhanced Raman spectroscopy (SERS) and surface plasmon reso-
nance are the two powerful optical biosensors with a unique feature of label-free 
sensing, as the analytes need no pre-processing to be labeled before sensing 
events and thus eliminate the false-positive or false-negative biosensing results 
induced by the labels. The first commercial product of SPR biosensor appeared 
in 1990 by the company of Pharmacia (named Biacore afterwards). Since then, 
more than 1000 papers were published annually using commercial SPR biosen-
sors [88]. Most of these commercial SPR biosensors are bulky and only laboratory 
based. The development of plasmonic-based biosensors in the field of POC was 
reviewed in [43] together with recent advances in surface chemistry, substrate 
fabrication, and microfluidic integration. Here we explore a bit wider which is not 
limited to POC but microfluidic-integrated biosensors. In most of the researches 
mentioned below, the microfluidic structure usually serves as the sample han-
dling unit.
Tunc I et al. [39] presented the molecular specificity of Raman spectroscopy 
together with self-assembled monolayer of metallic AuNPs to detect CA125 
 antibody–antigen molecules. Highly enhanced electromagnetic fields localized 
around neighboring AuNPs provide hot-spot construction due to the spatial 
 distribution of SERS enhancement on the CA125 proteins at nM concentration level.
Carneiro M et al. [41] reported the detection of carcinoembryonic antigen (CEA) 
in SERS using two different bioreceptors for CEA, i.e., a molecularly imprinted 
polymer (MIP) and a natural antibody. The MIP acted as a pre-concentration 
scheme for the CEA, while the natural antibody signals the presence of CEA on the 
MIP platform. The MIP film was first incubated in the sample containing CEA and 
next incubated in SERS tag, which is gold nano-stars coupled to 4-aminothiophenol 
(4-ATP) as Raman reporter, so the MIP acted as a pre-concentration scheme for the 
CEA. Then the MIP was exposed to the natural CAE antibody. A sensitivity down to 
1.0 ng/mL was reported.
Zhu JY et al. [89] presented a biosensor that can be used for clinical diagnosis. 
This biosensor is based on localized surface plasmon resonance integrated with a 
biomimetic microfluidic “adipose-tissue-on-chip” platform for an in situ label-free, 
high-throughput, and multiplexed cytokine secretion analysis of obese adipose 
tissue. It was stated that this system enables simultaneous measurements of 
 pro-inflammatory (IL-6 and TNF-alpha) and anti-inflammatory (IL-10 and IL-4) 
cytokines secreted by the adipocytes and macrophages and identified stage-specific 
cytokine secretion profiles from a complex milieu during obesity progression.
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In the research of [90], the plasmonic biosensor integrated the microfluidic 
unit for plasma separation, allows the in-line separation of plasma directly from 
the bloodstream without any pre-processing outside the device, and channels it 
to the active detection area, where inorganic cerium oxide nanoparticles function 
as local selective dopamine binding sites through strong surface redox reaction. A 
detection limit of dopamine was achieved at 100 fM concentration in simulated 
body fluid and 1 nM directly from blood without any prior sample preparation. 
This  demonstration shows the feasibility of the practical implementation of the 
proposed plasmonic system in detection of a variety of biomarkers directly from 
the complex biological fluids. Li XK et al. [91] reported the plasmonic biosensor 
integrated a multifunctional microfluidic system with small-volume microchamber 
and regulation channels for reliable monitoring of cytokine secretion from indi-
vidual cells for hours.
Besides the traditional plasmonic materials, graphene has recently received 
more and more attention in the field of both labeled and label-free sensing, because 
of its ability to harness electromagnetic fields, strong light-matter interaction of 
graphene layer, and its highly tunable optical properties [40]. Liu HP et al. [40] 
simulated the detection capacity of the graphene plasmonic biosensor using three-
dimensional finite difference time domain method. Numerical results showed that 
the maximum sensitivity and figure of merit of the biosensor are 333.3 nm/RIU and 
16.665 RIU, respectively.
Fluorescence is the other powerful optical biosensor which labels analytes and 
promises high sensitivity and specificity in target recognition. Raducanu VS et al. 
[56] reported a direct fluorescent signal transducer embedded in a DNA aptamer for 
versatile metal-ion detection. This sensor embedded with guanine-rich DNA aptamer 
internally coupled with Cy3 fluorescent dye that measures directly the DNA confor-
mational changes upon metal-ion binding. Our signal transducer is environmentally 
sensitive that is internally coupled to the DNA aptamer. Potassium ion concentration 
was successfully measured in a variety of aqueous and biological test samples.
5.2.2 Electrochemical biosensors
There are plenty of researches on electrochemical biosensors, and majority 
of the commercialized biosensors belong to this category. Here we only present 
the electrochemical biosensors integrated with microfluidics that possesses both 
miniaturized structure and high sensitivity.
Electrode-based chemoelectrical biosensors are the most common ones. Usually 
a working electrode and a blank/reference electrode are designed in such biosensor, 
and the samples cover both electrodes and generate a measurable electrical signal. 
Mi SL et al. [92] reported a sensitivity up to 567 nA mM(−1) mm(−2), and the limit 
of detection was 4.5 M (vs. Ag/AgCl as the reference electrode) in the detection of 
metabolic lactate concentrations in HepG2 cells cultured with cancer drugs.
Evans D et al. [93] demonstrated a fully integrated microfluidic amperometric 
enzyme-linked immunosorbent assay prototype using a commercial interferon 
gamma release assay as a model antibody binding system. What is unique in this 
research is that the assay cell is based on a printed circuit board (PCB) and the micro-
fluidic assay chemistry was engineered to take place on the Au-plated  electrodes 
within the cell. All components were manufactured exclusively via  standard 
 commercial PCB fabrication processes. A detection limit comparable to high-end 
commercial systems and a short diagnosis time of 8 minutes were demonstrated.
Silicon nanowire field-effect transistor is one of the most sensitive biosens-
ing techniques, but it is limited to analytes that carry charges. Weakly charged or 
uncharged analytes can hardly be detected [11]. Evans D et al. [31] presented a 
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method of immobilizing bioreceptors on the silicon nanowire sensing surface only, 
comparing with the traditional methods in which a large surrounding substrate 
is also covered with bioreceptors, and it was proven that restricting the surface 
modification substantially improves the sensitivity.
Besides silicon nanowire, copper nanowire is adopted in electrochemical biosen-
sors [94]. In [94], microfluidic chip is coupled to copper nanowires for the fast 
diagnosis of galactosemia in precious newborn urine samples. Galactosemia is a rare 
disease that is diagnosed through the identification of different metabolite profiles. 
The specific detection of galactose 1-phosphate (Gal 1-P), galactose (Gal), and 
uridyl diphosphate galactose (UDP-Gal) confirms type I, II, and III galactosemia 
diseases. The detection is extremely fast which is less than 350 s, required negligible 
urine sample consumption, and displayed impressive signal-to-noise characteristics 
and excellent reproducibility.
Oliveira MC et al. [95] presented an amperometric biosensor using a screen-
printed electrode modified with carbon nanotubes and nickel ions for the detection 
of glucose, which is characterized by the chemical oxidation of carbohydrate by 
NiOOH. Under optimized conditions, a limit of detection 3.9 μmol/L and a limit 
of quantification of 13 μmol/L were reported. The effect of concomitant species 
such as ascorbic acid, dopamine, and uric acid was investigated, and this method 
was successfully applied for the determination of glucose in a commercial blood 
serum human (original and spiked) sample. What is unique in this research is that 
the microfluidic system was assembled on a 3D-printed platform constructed with 
acrylonitrile butadiene styrene and integrated with nine cotton threads, providing a 
stable flow rate.
5.2.3 Colorimetric biosensors
Plenty of reports are available on colorimetric biosensors integrated with 
microfluidics, e.g., [27, 28, 96–98]; most of the reports highlighted the features of 
cost-effectiveness and miniaturization. Different from three other kinds of biosen-
sors, the materials adopted for the integrated microfluidic structures are usually not 
PDMS, but paper for the majority and cloth in some researches. Currently majority 
of the researches focus on the applications in food safety [22, 27, 96] and heavy 
metal detection [67, 99, 100] in aqueous environment. The researches in the appli-
cation of biological analytes are quite limited, due to the natures of analytes and 
bioreceptors and the environment conditions in order to keep the activities of both 
analytes and bioreceptors.
Fraser LA et al. [101] presented a malaria biosensor whereby aptamers are 
coated onto magnetic microbeads for magnet-guided capture, wash, and detection 
of the biomarker. A biosensor incorporating three separate microfluidic chambers 
was designed to enable such magnet-guided equipment-free colorimetric detection 
of PfLDH. The biosensor showed high sensitivity and specificity when detecting 
PfLDH using both in vitro cultured parasite samples and clinical samples from 
malaria patients.
5.2.4 Piezoelectric biosensors
The research of piezoelectric biosensor integrated with microfluidics is quite 
underdeveloped so far. Possible reasons could be the lower sensitivity, poor biocom-
patibility, and complicated fabrication.
Yamaguchi M. [82] proposed a mass sensor based on mechanical resonance that 
incorporates a disk-shaped mechanical resonator, a separate piezoelectric element 
used to excite vibrations in the resonator, and a microfluidic mechanism. Electrical 
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power is used to actuate the piezoelectric element, leaving the resonator free from 
power lines. This sensor was reported to be suitable to analyze the concentration of 
a salivary hormone, cortisol in human saliva samples.
6. Future research interests
Future possible research interests in the field of microfluidic-integrated biosen-
sors are proposed as the following:
• Exploration of materials for both microfluidics and nanofluidics in different 
application scenarios. Besides PDMS, the exploration of other materials, e.g., 
engineering polymers, traditional glass, silicon, or metal, in special applica-
tions that requires high chemical stability, high thermal stability, unique 
optical properties, and/or special mechanical properties.
• Fabrication of microfluidics and nanofluidics and structures (e.g., valves, 
mixers).
• Microfluidics with high chemical and thermal stability for special applications.
• Integration of microfluidics and nanofluidics with sensors to form complete 
and functional systems that require no professional operations and ease in 
applications, e.g., LOC, etc.
• Integration of microfluidics with data processing algorithms. The application 
of machine learning in sensing data processing could enhance the performance 
of biosensors in specialized environments.
• Integration of microfluidics with communication techniques. Synchronization 
of sensing data with relevant users, remote control of the biosensors, and big 
data analysis of special sensing networks can be realized.
7. Conclusions
The state-of-the-art advances in biosensor development based on microfluidic 
technology have been reviewed in the book chapter with focus on the applications, 
challenges, and possible future research interests for each type of biosensor. It can 
be envisioned that microfluidic-based biosensors will remain a hot topic of inves-
tigations because of the ever-increasing demands in various applications ranging 
from industry to biomedical detection. The interests in microfluidic-integrated 
biosensors promise even more prospective future in these areas. It is applications in 
wearable biosensor; portable biosensor can be explored in the future with enhanced 
sensitivity, improved stability, and miniaturized structure.
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